Media
2020-09-08LL
Safety is Top Priority in COVID-19 Vaccine #WeStandWithScience
Media
2020-09-03LL
Sanofi and GSK Initiate Phase 1/2 Clinical Trial of COVID-19 Vaccine
Driven by the Science: Small-Molecule Protein Degraders
Sanofi scientists are using protein degrader technology to design and develop drugs that could destroy key proteins in different types of cancer
The Fight against COVID-19
As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients
Supporting People with Cancer during COVID-19
Despite the challenges caused by COVID-19, Sanofi continues to support the patient communities it serves—including the cancer community
The Last Mile: Innovative Breakthrough in Sleeping Sickness Treatment
Sanofi and DNDi are co-developing a second innovative treatment to strengthen their support for the sustainable elimination of sleeping sickness
Join Us!
You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives
-
Press releases2020-09-22MMMM DD YYYYCHMP recommends approval of Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older
